At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that can dramatically improve human health. We enable life science researchers and drug hunters to look at the proteome from every angle with our versatile portfolio of proprietary proteomics services, software, and kits. These solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research.

News

04.01.2023 Bruker acquires a majority stake in Biognosys (startupticker.ch)
04.10.2022 A new base for three Swiss startups (startupticker.ch)
21.10.2021 Growing together with partners (startupticker.ch)
13.07.2017 Biognosys secures $5 Million in C round (startupticker.ch)
13.07.2017 Biognosys secures $5 Million in C round (startupticker.ch)
12.01.2016 Biognosys raises new funds for US expansion (startupticker.ch)
31.07.2015 Biognosys and Biodesix work together (startupticker.ch)
10.01.2014 New financing for Biognosys (startupticker.ch)
21.10.2013 US patent awarded to Biognosys (startupticker.ch)
01.11.2011 Biognosys raises CHF 2.7m (startupticker.ch)

Milestones/News

Documents